These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19846865)

  • 1. Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.
    Gil M; Bieniasz M; Wierzbicki A; Bambach BJ; Rokita H; Kozbor D
    J Immunol; 2009 Nov; 183(10):6808-18. PubMed ID: 19846865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
    Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D
    Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.
    Wierzbicki A; Gil M; Ciesielski M; Fenstermaker RA; Kaneko Y; Rokita H; Lau JT; Kozbor D
    J Immunol; 2008 Nov; 181(9):6644-53. PubMed ID: 18941255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice.
    Komorowski M; Tisonczyk J; Kolakowska A; Drozdz R; Kozbor D
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30149659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
    Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
    Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma.
    Koike N; Pilon-Thomas S; Mulé JJ
    J Immunother; 2008 May; 31(4):402-12. PubMed ID: 18391755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens.
    Kozbor D
    Immunol Res; 2010 Mar; 46(1-3):23-31. PubMed ID: 19763891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.
    Lapteva N; Aldrich M; Weksberg D; Rollins L; Goltsova T; Chen SY; Huang XF
    J Immunother; 2009; 32(2):145-56. PubMed ID: 19238013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.
    Schuurhuis DH; van Montfoort N; Ioan-Facsinay A; Jiawan R; Camps M; Nouta J; Melief CJ; Verbeek JS; Ossendorp F
    J Immunol; 2006 Apr; 176(8):4573-80. PubMed ID: 16585547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
    Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.
    Jing W; Gershan JA; Johnson BD
    Blood; 2009 Apr; 113(18):4449-57. PubMed ID: 19182203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
    Ma J; Wang YL; Hu HM; Fox BA; Si LS
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors.
    Lerret NM; Rogozinska M; Jaramillo A; Marzo AL
    PLoS One; 2012; 7(7):e41240. PubMed ID: 22911764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.
    Zizzari IG; Veglia F; Taurino F; Rahimi H; Quaglino E; Belleudi F; Riccardo F; Antonilli M; Napoletano C; Bellati F; Benedetti-Panici P; Torrisi MR; Frati L; Nuti M; Rughetti A
    J Mol Med (Berl); 2011 Dec; 89(12):1231-40. PubMed ID: 21845448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice.
    Wang LX; Li Y; Yang G; Pang PY; Haley D; Walker EB; Urba WJ; Hu HM
    Eur J Immunol; 2010 May; 40(5):1375-85. PubMed ID: 20186876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.